For Clinicians
Our Technology: Inter-fibrinous Pulsated Gas & Drug Technology
ExoSurge Inter-fibrinous Pulsated Gas Technology (IPG) is the first and only technology of its kind specially engineered to permanently remove the penile fibrosis and plaques that trigger a Peyronie's diagnosis – and do so safely and without collateral tissue damage.
ExoSurge IPG is capable of selective disruption of the fibrotic masses that make up Peyronie's plaques. That means can you not only remove Peyronie's fibrosis from long established cases, but you can also immediately treat acute penile injury cases long before the plaque gets established. Additionally, using standard duplex Doppler sonography images, you'll be able to diagnose and effectively treat early-stage cases with diffuse plaques or minor fibrosis long before those men develop symptomatic Peyronie's conditions.
ExoSurge Inter-fibrinous Pulsated Gas Technology (IPG) offers clinicians the ability to safely and permanently remove the penile fibrosis and plaque that trigger any and all Peyronie's symptomatology with no patient downtime and no anesthesia in a well-tolerated 20-minute procedure. The procedure can even be performed by support staff including Nurse Practitioners, Physician Assistants, or primary care physicians.
ExoSurge® IPG FOR PERMANENT REMOVAL OF PENILE FIBROSIS
In order for Peyronie's care to become an attractive and growing part of your practice, you need to be able to a permanent solution where improvement is measurably confirmed through baseline and follow up duplex Doppler sonogram imagery and where most or all of the cost of care is covered by insurance.
Our research resulted in a breakthrough discovery of what actually causes a Peyronie's diagnosis, and how to break up and permanently dissolve the fibrosis and penile plaques that trigger all the potential negative outcomes associated with the disease.

In order for Peyronie's care to become an attractive and growing part of your practice, you need to be able to a permanent solution where improvement is measurably confirmed through baseline and follow up duplex Doppler sonogram imagery and where most or all of the cost of care is covered by insurance.
Our research resulted in a breakthrough discovery of what actually causes a Peyronie's diagnosis, and how to break up and permanently dissolve the fibrosis and penile plaques that trigger all the potential negative outcomes associated with the disease.

Reimagine Peyronie's Patient Care
Peyronie’s Care Reimagined: for Clinicians
Urologists will soon no longer just be treating Peyronie’s patient symptoms, but providing curative outcomes, like:
- Prevention: We’ve developed testing protocols that identify future Peyronie’s patients far in advance of symptomatic penile fibrosis and created a curative treatment method that will help ensure a Peyrpnie’s free future.
- Early Stage Detection and treatment: Patients just at the cusp off developing a severe Peyronie’s diagnosis can soon be identified and completely healed
- Active Stage Resolution and Repair: Long standing AUA-guidelines and protocols for active stage cases will completely evolve. ExoSurge therapeutics not only resolve pain following acute penile injury but also keep the fibrous plaques from forming for patients.
- Established Cases: Calcified and Non-calcified: The front line focus of ExoSurge are following FDA approval and adaption will mostly be focused on well established existing cases. We’ve created varied protocols based upon the size, density and location of fibrous plaques as well as each patient’s health dynamics. No patient will be excluded from creative care.
- Plication Surgery Adjunct: ExoSurge co-founder Kennthe J. Carney’s recent innovation establishing a standard amount of fibrous plaque removal and change in density for penile fibrosis as an adjunct to performing Peyronie's plication surgery for patients resulting in no loss to penile length while creating a faster and better solution for severely curved Peyronie’s cases.
- Established Cases: Asymptomatic Case Solutions. Presently, most patients who present to urologist with visible fibrosis revealed during an ultrasound but no curvature are asked “how bothersome” is the issue. Going forward, urologists will be able to conservatively remove the fibrous plaques in these cases.
Preventative Peyronie's Care
We've developed testing which provides indication if a patient is at high risk of ending up with Peyronie's in the future urologists can include as a part of routine screenings.
Active Phase Peyronie's Solution
ExoSurge® proved 100% effective treating recent acute penile injury cases still in the active phase.
Not only did ExoSurge therapy eliminate acute pain within about a week after starting treatments but also healed injured tissue and halted the build up of fibrosis before it became a problem in all cases.
Established Cases: Treating Asymptomatic Peyronie's Disease
The methodical IPG process of breaking down and permanently removing penile fibrosis and plaques is a game-changing new tool for Peyronie’s care.
It's not curvature / symptom-based. Rather, it treats the underlying cause.
Asymptotic patients now get effective care.
Early Stage Peyronie's Detection and Repair
ExoSurge® paves the way for preventative care in asymptomatic patients who exhibit plaque and fibrosis during pre-screening ultrasound while being evaluated for other urologic disorders such as erectile dysfunction.
The technology proved effective treating diffuse plaque as discovered from duplex Doppler sonogram images (early stage Peyronie’s), completely healing the disease before it became problematic.
Established Case: Healing all cases regardless of pre-existing conditions or calcified plaque
ExoSurge® Inter-fibrinous Pulsated Gas and Drug Technology (IPG) delivers a treatment that is well tolerated, generates no heat or collateral tissue damage, requires no patient downtime or anesthesia, and works without regard to patient skin color.
The methodical IPG process of breaking down and permanently removing penile fibrosis and plaques is a game-changing new tool for Peyronie’s care whether with fibrous tissue from recent injury, thick and dense long established fibrotic tissue, even heavily calcified plaque.
New & Improved Peyronie's Surgery Pathways
Five issued patents, 12 patents and provisionals filed both nationally and internationally
ExoSurge® IPG: COMPLETE PEYRONIE'S CARE FOR ALL UROLOGISTS
The ExoSurge® IPG device is capable of selective disruption of the fibrotic masses that make up Peyronie's plaques. That means can you not only remove Peyronie's fibrosis from long established cases, but you can also immediately treat acute penile injury cases long before the plaque gets established.
As a conservative therapeutic procedure requiring no downtime or anesthesia, this represents a new way to treat Peyronie's disease and improve patient care.
Key Advantages of ExoSurge IPG Technology Include:
1. ExoSurge® Inter-fibrinous Pulsated Gas and Drug Technology (IPG) delivers a treatment that is well tolerated, generates no heat or collateral tissue damage, requires no patient downtime or anesthesia, and works without regard to patient skin color.
2. The methodical IPG sequenced, pulsated gas injections are able to penetrate dense plaques and allow for subsequent efffective drug injections that together permanently remove penile fibrosis and plaques. It's a game-changing new tool for Peyronie’s care.
3. ExoSurge® proved effective treating recent acute penile injury cases still in the active phase. Not only did ExoSurge therapy eliminate acute pain within about a week after starting treatments but also healed injured tissue and halted the build up of fibrosis before it became a problem in 100% of cases.
4. The technology proved effective treating diffuse plaque as discovered from duplex Doppler sonogram images (early stage Peyronie’s), completely healing the disease before it became problematic.
5. ExoSurge® paves the way for preventative care in asymptomatic patients who exhibit plaque and fibrosis during pre-screening ultrasound while being evaluated for other urologic disorders such as erectile dysfunction.
6. ExoSurge® treatments can be performed by a urologist or their support staff such as a nurse practitioner, physician’s assist or licensed medical doctor.
7. The device can conveniently be stored in the corner of an exam room between uses. Its complete size is approximately 48 inches tall by 24 inches wide.
Prospective Clinical Trials
We plan to conduct clinical trials in early 2023, including human trials, conducted under IRB supervision which will have been submitted to the FDA for permanent removal of penile fibrosis and Peyronie's plaques.
Following achievement of an FDA-indication, we will seek insurance reimbursement for all or see aspects of ExoSurge treatments will launch the ExoSurge® Inter-fibrinous Pulsated Gas Technology (IPG) (the device is not currently available for sale) into domestic US, followed by international distribution and position the technology as the standard of care for Peyronie's disease.
If you are a urologic clinician with potential interest with participating in our upcoming prospective clinical trials, please click here
If you are a Peyronie's patient and would like to potentially participate in our upcoming prospective national clinical trials, please click here.
We plan to conduct clinical trials in early 2023, including human trials, conducted under IRB supervision which will have been submitted to the FDA for permanent removal of penile fibrosis and Peyronie's plaques.
Following achievement of an FDA-indication, we will seek insurance reimbursement for all or see aspects of ExoSurge treatments will launch the ExoSurge® Inter-fibrinous Pulsated Gas Technology (IPG) (the device is not currently available for sale) into domestic US, followed by international distribution and position the technology as the standard of care for Peyronie's disease.
If you are a urologic clinician with potential interest with participating in our upcoming prospective clinical trials, please click here
If you are a Peyronie's patient and would like to potentially participate in our upcoming prospective national clinical trials, please click here.
To learn more about our diagnostics and Peyronie's treatments with ExoSurge technology right away, please visit our clinical website and schedule a "one on one" phone consultation or a visit to our clinic in the Buckhead area of Atlanta, Georgia.
Stay Up To Date
If you are a Peyronie's patient who has interest in participating in one of our upcoming clinical trials around the United States, please click here
If you are a urologic clinician who has a potential interest with being involved in our upcoming prospective clinical trials, please click here
If you would like to stay abreast of our progress during clinical trials and in the future, please click here:
Sign up to follow our story and to watch us grow!